CAR- T and also mobile gene treatments are too pricey

.Mother Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and technology transfer may provide cellular gene treatments at an affordable cost to patients across the world.